IMMvention Therapeutix
IMMvention was founded in 2017 by scientists from the School of Medicine and the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill who specialized in immunology and innate immunity.
Last updated on
About IMMvention Therapeutix
Founded
2017Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$9MCategory
Industry
BiotechnologyLocation
City
DurhamState
North CarolinaCountry
United StatesIMMvention Therapeutix
Find your buyer within IMMvention Therapeutix
Tech Stack (21)
